Inequalities and Institutions that Benefit Good Apples

被引：1

作者：

Zietsma, Charlene ^{[1
]}

机构：

[1] Penn State Univ, University Pk, PA 16802 USA

来源：

JOURNAL OF MANAGEMENT INQUIRY | 2021年 / 30卷 / 04期

关键词：

Diversity; allies; inequality; career structures; work-life; GENDER BIAS; WOMEN;

D O I：

10.1177/10564926211030430

中图分类号：

C93 [管理学];

学科分类号：

12 ; 1201 ; 1202 ; 120202 ;

摘要：

I describe three types of inequalities that benefit "good apples" and harm women in Academe: inequality of recognition, inequality of effort required, and inequality in societal institutions around home and career. I then describe three hard things that "good apples" can do, focusing on the institutional level: building awareness, changing structures and adapting social norms.

引用

页码：472 / 475

页数：4

共 50 条

[1] Good Apples/Bad Apples
Melo, Alexandre
[J]. ARTFORUM INTERNATIONAL, 2019, 58 (01): : 276 - 277
[2] Good apples: behind every bite
Colfer, Carol J. Pierce
[J]. AGRICULTURE AND HUMAN VALUES, 2018, 35 (03) : 735 - 736
[3] Rural financial institutions - Mixing apples with oranges
Kaladhar, K
[J]. ECONOMIC AND POLITICAL WEEKLY, 1997, 32 (25) : 1503 - 1503
[4] AUSTRALIAN APPLES AND PEARS - OUTLOOK IS GOOD
不详
[J]. FOREIGN AGRICULTURE, 1971, 9 (05): : 7 - &
[5] Good apples: behind every bite
Weiler, Anelyse M.
[J]. FOOD CULTURE & SOCIETY, 2018, 21 (04) : 585 - 586
[6] Inequalities, institutions, and forest commons
Andersson, Krister
Agrawal, Arun
[J]. GLOBAL ENVIRONMENTAL CHANGE-HUMAN AND POLICY DIMENSIONS, 2011, 21 (03): : 866 - 875
[7] The benefit of being good
Mark Buchanan
[J]. Nature Physics, 2010, 6 : 635 - 635
[8] The benefit of being good
Buchanan, Mark
[J]. NATURE PHYSICS, 2010, 6 (09) : 635 - 635
[9] Good Apples, Bad Apples: Sorting Among Chinese Companies Traded in the US
Ang, James S.
Jiang, Zhiqian
Wu, Chaopeng
[J]. JOURNAL OF BUSINESS ETHICS, 2016, 134 (04) : 611 - 629
[10] Is absolute benefit a good estimation of treatment benefit?
Kassae, B.
Gueyffier, F.
Boissel, J. P.
Boutitie, F.
Cucherat, M.
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 13 - 13

← 1 2 3 4 5 →